Inventor · disambiguated record
Jean-Christophe Marine
Also filed as: MARINE JEAN-CHRISTOPHE
10 granted patents·3 pending applications·25 citations·filing 2007–2020
83Inventor score
Top patents by PatentIndex Score
13 records- 0192US9408885B2Combinations of therapeutic agents for treating melanomaVIB VZW·Filed 2012·Granted Aug 9, 2016·18 cites·12 claims
- 0281US10767182B2Direct and selective inhibition of MDM4 for treatment of cancerVIB VZW·Filed 2015·Granted Sep 8, 2020·3 cites·18 claims
- 0371US8470785B2Method for treating ocular cancerDYER MICHAEL A·Filed 2011·Granted Jun 25, 2013·2 cites·4 claims
- 0466US9783803B2Inhibition of NEAT1 for treatment of solid tumorsVIB VZW·Filed 2015·Granted Oct 10, 2017·1 cites·13 claims
- 0562US9078895B2Method for treating ocular cancerST JUDE CHILDRENS RES HOSPITAL·Filed 2013·Granted Jul 14, 2015·0 cites·4 claims
- 0661US12139712B2Direct and selective inhibition of MDM4 for treatment of cancerVIB VZW·Filed 2020·Granted Nov 12, 2024·0 cites·5 claims
- 0761US9821004B2Inhibition of a lncRNA for treatment of melanomaVIB VZW·Filed 2014·Granted Nov 21, 2017·0 cites·11 claims
- 0859US8614192B2Method for treating ocular cancerDYER MICHAEL A·Filed 2007·Granted Dec 24, 2013·1 cites·2 claims
- 0955USRE48801EInhibition of a lncRNA for treatment of melanomaVIB VZW·Filed 2014·Granted Nov 2, 2021·0 cites·15 claims
- 1049USRE48856EInhibition of NEAT1 for treatment of solid tumorsVIB VZW·Filed 2015·Granted Dec 21, 2021·0 cites·19 claims
- 1141US2021008047A1Targeting minimal residual disease in cancer with rxr antagonistsVIB VZW·Filed 2019·Application pending·0 cites
- 1241US2021010089A1Tumor minimal residual disease stratificationVIB VZW·Filed 2019·Application pending·0 cites
- 1337US2021008070A1Targeting minimal residual disease in cancer with cd36 antagonistsVIB VZW·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean-Christophe Marine files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →